Metraipolis › archive › dc_2ebfc99dfae3

Allogeneic processed thymus tissue — Wikipedia (en)

Source: Wikipedia (en)
Original: https://en.wikipedia.org/wiki/Allogeneic_processed_thymus_tissue
License (as archived): CC-BY-SA-4.0
Archived: 2026-10-06T08:17:57.901Z
SHA-256 of the archived text: 7fde469add04134d43cf38fcc3bf80bdb0f44fe7c2d768d1df87e26ede20b3df
Stable URL of this page: https://metraipolis.com/documento/dc_2ebfc99dfae3

How to cite

Allogeneic processed thymus tissue — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Allogeneic_processed_thymus_tissue (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_2ebfc99dfae3 (Metraipolis archive dc_2ebfc99dfae3, sha256 7fde469add04134d43cf38fcc3bf80bdb0f44fe7c2d768d1df87e26ede20b3df)

BibTeX

@misc{dc2ebfc99dfae3,
  title = {Allogeneic processed thymus tissue — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Allogeneic_processed_thymus_tissue},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_2ebfc99dfae3; sha256 7fde469add04134d43cf38fcc3bf80bdb0f44fe7c2d768d1df87e26ede20b3df},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Allogeneic_processed_thymus_tissue. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Allogeneic processed thymus tissue, sold under the brand name Rethymic, is a thymus tissue therapy used for the treatment of children with congenital athymia. It is administered via a one-time surgical procedure where the tissue slices are implanted into the quadriceps muscle. It takes six months or longer to reconstitute the immune function in treated people. The most common adverse reactions include high blood pressure, cytokine release syndrome, low blood magnesium levels, rash, low platelets, and graft versus host disease. Allogeneic processed thymus tissue was approved for medical use in the United States in October 2021. Allogeneic processed thymus tissue is the first thymus tissue product approved by the U.S. Food and Drug Administration (FDA). Allogeneic processed thymus tissue is composed of human allogeneic (donor-derived) thymus tissue that is processed and cultured, and then implanted into people to help reconstitute immunity (improve immune function) in people who are athymic. Dosing is patient customized, determined by the surface area of the allogeneic processed thymus tissue slices and the body surface area of the patient.

Tema degli esploratori: scienze della vita e salute (deposito sistematico; categoria «Immunology»).
Fonte: Wikipedia in inglese, voce «Allogeneic processed thymus tissue» — https://en.wikipedia.org/wiki/Allogeneic_processed_thymus_tissue
Wikidata Q109116548: «thymus tissue medical therapy» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q109116548
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Allogeneic_processed_thymus_tissue?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1371114158, consultata il 2026-10-06T07:49:25.425Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 87d1451eb361c6cb276f08272ee7d37bc9b1c0052a34da5a025f6d235c1c2eda